Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Biomarkers in Breast Cancer: An Old Story with a New End
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview
Vijayakumar Shrihastini, Pandiyan Muthuramalingam, Sivakumar Adarshan, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6222-6222
Open Access | Times Cited: 65
Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers
Haoyang Mi, Shamilene Sivagnanam, Courtney B. Betts, et al.
Cancer Research (2022) Vol. 82, Iss. 23, pp. 4359-4372
Open Access | Times Cited: 55
Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model
Álvaro Ruiz-Martínez, Chang Gong, Hanwen Wang, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 7, pp. e1010254-e1010254
Open Access | Times Cited: 46
Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma
Haoyang Mi, Won Jin Ho, Mark Yarchoan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Agent-based methods facilitate integrative science in cancer
Jeffrey West, Mark Robertson‐Tessi, Alexander R.A. Anderson
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 300-311
Open Access | Times Cited: 43
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
A comprehensive review of computational cell cycle models in guiding cancer treatment strategies
Chenhui Ma, Evren Gürkan-Çavusoglu
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Richard J. Sové, Babita K. Verma, Hanwen Wang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005414-e005414
Open Access | Times Cited: 35
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
Hanwen Wang, Chen Zhao, Cesar A. Santa‐Maria, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104702-104702
Open Access | Times Cited: 32
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition
Theinmozhi Arulraj, Hanwen Wang, Leisha A. Emens, et al.
Science Advances (2023) Vol. 9, Iss. 26
Open Access | Times Cited: 18
Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology
Theinmozhi Arulraj, Hanwen Wang, Alberto Ippolito, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 7
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery
Shuming Zhang, Atul Deshpande, Babita K. Verma, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2734-2748
Closed Access | Times Cited: 7
Systems biology of angiogenesis signaling: Computational models and omics
Yu Zhang, Hanwen Wang, Rebeca Hannah de Melo Oliveira, et al.
WIREs Mechanisms of Disease (2021) Vol. 14, Iss. 4
Open Access | Times Cited: 36
Systems-level computational modeling in ischemic stroke: from cells to patients
Geli Li, Yanyong Zhao, Wen Ma, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 5
Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model
Mehdi Nikfar, Hao‐Yang Mi, Chang Gong, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2750-2750
Open Access | Times Cited: 11
Predicting survival in prospective clinical trials using weakly-supervised QSP
Matthew West, Kenta Yoshida, Jiajie Yu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade
Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 45
Open Access | Times Cited: 3
From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers
Michael C. Luo, Elpiniki Nikolopoulou, Jana L. Gevertz
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Identification of indole-based natural compounds as inhibitors of PARP-1 against triple-negative breast cancer: a computational study
Sridhar Priyankha, V. Rajapandian, Kandhan Palanisamy, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2667-2680
Closed Access | Times Cited: 7
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting
Natsuki Furukawa, Vered Stearns, Cesar A. Santa‐Maria, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 12, pp. 1041-1056
Open Access | Times Cited: 12
Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial
Shuming Zhang, Atul Deshpande, Babita K. Verma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Fighting fire with fire: deploying complexity in computational modeling to effectively characterize complex biological systems
Alexis N. Prybutok, Jason Y. Cain, Joshua N. Leonard, et al.
Current Opinion in Biotechnology (2022) Vol. 75, pp. 102704-102704
Open Access | Times Cited: 6
Prognostic/predictive markers in systemic therapy resistance and metastasis in breast cancer
Evie Hobbs, Natalie Chen, Alphi Kuriakose, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 5
Predicting survival in prospective clinical trials using weakly-supervised QSP
Vincent Lemaire, Matthew West, Kenta Yoshida, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top